findmyKOL
Clinical trialNCT03601806CompletedPhase 2Interventional

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

SponsorAIDS Malignancy ConsortiumEnrollment26Human Immunodeficiency Virus 1 PositiveSkin Kaposi Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Kenya
  • Moi University School of Medicine

    Eldoret, Kenya

Malawi
  • Unc Project Malawi

    Lilongwe, Malawi

Uganda
  • Uganda Cancer Institute

    Kampala, Uganda

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Apr 2021
Primary completion
29 Nov 2024
Completion
10 Apr 2025
Last update posted
13 Apr 2026
Registered enrollment
26
Registry id
NCT03601806

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.